| Ms Alexis Beinlich, DO | |
|
2811 Tieton Dr, Yakima, WA 98902-3761 | |
| (509) 575-8000 | |
| Not Available |
| Full Name | Ms Alexis Beinlich |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 10 Years |
| Location | 2811 Tieton Dr, Yakima, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093148009 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | OP60838299 (Washington) | Secondary |
| 207R00000X | Internal Medicine | OP60838299 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginia Mason Memorial | Yakima, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yakima Valley Memorial Physicians | 1557391596 | 250 |
News Archive
Milliman, Inc., one of the premier global consulting and actuarial firms, announced today that their healthcare analytic platform, MedInsight, has achieved the National Committee for Quality Assurance certification for Healthcare Effectiveness Data and Information Set 2015 Measures. Since its introduction in 1993, HEDIS has evolved to become the gold standard in managed care performance measurement.
Today, March of Dimes Canada and the University of Toronto (U of T) signed a $1.5 million agreement to advance research in recovery from brain injuries and stroke, making the donation to the University the largest made by the national charitable organization in its over 60 year history.
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from its completed Phase 2 clinical study of OncoVEX (GM-CSF) for the treatment of advanced melanoma has been published in the Journal of Clinical Oncology (JCO). The previously announced top line results report a high objective durable response rate and a high complete response rate, combined with a relatively benign side effect profile.
About one-third of CT examinations performed following an inconclusive abdominal ultrasound examination have positive findings, according to a study of 449 patients at Massachusetts General Hospital in Boston.
Children with acute lymphoblastic leukemia with certain genetic variations can have a different response to anti-cancer treatment than other patients, according to a study in the January 28 issue of JAMA, the Journal of the American Medical Association.
› Verified 5 days ago
| Entity Name | Yakima Valley Memorial Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306933940 PECOS PAC ID: 1557391596 Enrollment ID: O20050818000714 |
News Archive
Milliman, Inc., one of the premier global consulting and actuarial firms, announced today that their healthcare analytic platform, MedInsight, has achieved the National Committee for Quality Assurance certification for Healthcare Effectiveness Data and Information Set 2015 Measures. Since its introduction in 1993, HEDIS has evolved to become the gold standard in managed care performance measurement.
Today, March of Dimes Canada and the University of Toronto (U of T) signed a $1.5 million agreement to advance research in recovery from brain injuries and stroke, making the donation to the University the largest made by the national charitable organization in its over 60 year history.
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from its completed Phase 2 clinical study of OncoVEX (GM-CSF) for the treatment of advanced melanoma has been published in the Journal of Clinical Oncology (JCO). The previously announced top line results report a high objective durable response rate and a high complete response rate, combined with a relatively benign side effect profile.
About one-third of CT examinations performed following an inconclusive abdominal ultrasound examination have positive findings, according to a study of 449 patients at Massachusetts General Hospital in Boston.
Children with acute lymphoblastic leukemia with certain genetic variations can have a different response to anti-cancer treatment than other patients, according to a study in the January 28 issue of JAMA, the Journal of the American Medical Association.
› Verified 5 days ago
| Entity Name | Memorial Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962938183 PECOS PAC ID: 4789733494 Enrollment ID: O20100602000561 |
News Archive
Milliman, Inc., one of the premier global consulting and actuarial firms, announced today that their healthcare analytic platform, MedInsight, has achieved the National Committee for Quality Assurance certification for Healthcare Effectiveness Data and Information Set 2015 Measures. Since its introduction in 1993, HEDIS has evolved to become the gold standard in managed care performance measurement.
Today, March of Dimes Canada and the University of Toronto (U of T) signed a $1.5 million agreement to advance research in recovery from brain injuries and stroke, making the donation to the University the largest made by the national charitable organization in its over 60 year history.
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from its completed Phase 2 clinical study of OncoVEX (GM-CSF) for the treatment of advanced melanoma has been published in the Journal of Clinical Oncology (JCO). The previously announced top line results report a high objective durable response rate and a high complete response rate, combined with a relatively benign side effect profile.
About one-third of CT examinations performed following an inconclusive abdominal ultrasound examination have positive findings, according to a study of 449 patients at Massachusetts General Hospital in Boston.
Children with acute lymphoblastic leukemia with certain genetic variations can have a different response to anti-cancer treatment than other patients, according to a study in the January 28 issue of JAMA, the Journal of the American Medical Association.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Alexis Beinlich, DO 2811 Tieton Dr, Yakima, WA 98902-3761 Ph: () - | Ms Alexis Beinlich, DO 2811 Tieton Dr, Yakima, WA 98902-3761 Ph: (509) 575-8000 |
News Archive
Milliman, Inc., one of the premier global consulting and actuarial firms, announced today that their healthcare analytic platform, MedInsight, has achieved the National Committee for Quality Assurance certification for Healthcare Effectiveness Data and Information Set 2015 Measures. Since its introduction in 1993, HEDIS has evolved to become the gold standard in managed care performance measurement.
Today, March of Dimes Canada and the University of Toronto (U of T) signed a $1.5 million agreement to advance research in recovery from brain injuries and stroke, making the donation to the University the largest made by the national charitable organization in its over 60 year history.
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the data from its completed Phase 2 clinical study of OncoVEX (GM-CSF) for the treatment of advanced melanoma has been published in the Journal of Clinical Oncology (JCO). The previously announced top line results report a high objective durable response rate and a high complete response rate, combined with a relatively benign side effect profile.
About one-third of CT examinations performed following an inconclusive abdominal ultrasound examination have positive findings, according to a study of 449 patients at Massachusetts General Hospital in Boston.
Children with acute lymphoblastic leukemia with certain genetic variations can have a different response to anti-cancer treatment than other patients, according to a study in the January 28 issue of JAMA, the Journal of the American Medical Association.
› Verified 5 days ago
Daniel Doornink, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 602 E Nob Hill Blvd, Yakima, WA 98901 Phone: 509-248-3334 Fax: 509-453-6144 | |
Robert M Williams, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 3909 Creekside Loop, Suite 130, Yakima, WA 98902 Phone: 509-248-6616 Fax: 509-248-4983 | |
Erik Albert Monick, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 406 S 30th Ave, Suite 101, Yakima, WA 98902 Phone: 509-248-7715 | |
George J Hotchko, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3003 Tieton Dr, Suite 320, Yakima, WA 98902 Phone: 509-452-3765 Fax: 509-452-3435 | |
Sajal Kumar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 Holton Ave, Suite 100, Yakima, WA 98902 Phone: 509-248-6292 Fax: 509-248-9134 | |
Dr. Rosa Maria Martinez, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1111 W Spruce St, Yakima, WA 98902 Phone: 509-576-7064 Fax: 509-576-0679 | |
Dr. Siva Krishna Mannem, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 808 N 39th Ave, Yakima, WA 98902 Phone: 509-574-3400 Fax: 509-574-3464 |